SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001104659-18-050310
Filing Date
2018-08-08
Accepted
2018-08-08 06:52:04
Documents
63
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q/A a18-18342_110qa.htm 10-Q/A 684669
2 EX-31.1 a18-18342_1ex31d1.htm EX-31.1 10681
3 EX-31.2 a18-18342_1ex31d2.htm EX-31.2 10254
4 EX-32.1 a18-18342_1ex32d1.htm EX-32.1 8523
  Complete submission text file 0001104659-18-050310.txt   4621362

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT lptx-20180331.xml EX-101.INS 984069
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lptx-20180331.xsd EX-101.SCH 50050
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lptx-20180331_cal.xml EX-101.CAL 31101
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lptx-20180331_def.xml EX-101.DEF 190695
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT lptx-20180331_lab.xml EX-101.LAB 428664
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lptx-20180331_pre.xml EX-101.PRE 337731
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

IRS No.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-37990 | Film No.: 18999724
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences